Combining Melphalan Percutaneous Hepatic Perfusion With Ipilimumab Plus Nivolumab for Advanced Uveal Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial
Cardiovasc Intervent Radiol 2023 Jan 09;[EPub Ahead of Print], TML Tong, MC Burgmans, FM Speetjens, AR van Erkel, RW van der Meer, CSP van Rijswijk, MA Jonker-Bos, CFM Roozen, M Sporrel-Blokland, J Lutjeboer, EL van Persijn van Meerten, CH Martini, RWM Zoethout, FGJ Tijl, CU Blank, E KapiteijnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.